@article {4973,
	title = {Management of Renal Cell Carcinoma and Other Renal Masses in the Kidney Graft},
	volume = {21},
	year = {2020},
	month = {Feb},
	pages = {8},
	abstract = {Purpose of review: Renal masses in the kidney graft pose an important clinical dilemma, balancing graft function against the need for cancer control.

Recent findings: Donor origin cancers in the renal graft can be classified as {\textquoteright}donor transmitted{\textquoteright} or {\textquoteright}donor derived{\textquoteright}. The landmark TracerX Renal changed our understanding of renal cell carcinoma oncogenesis, demonstrating that key mutations in childhood lead to clinically apparent tumours in later life. Identified pre-operatively, contemporary evidence suggests that masses excised prior to transplantation result in acceptable oncologic safety and graft function. Identified post-operatively management mirrors that for a mass in a solitary kidney in the non-transplant population, with focus on a nephron-sparing approach. With growing number of kidney transplants each year, ageing donors, and increasing graft survival, masses in the renal graft are likely to become a more prevalent clinical conundrum.},
	doi = {10.1007/s11934-020-0959-4},
	author = {Warren, H and Olsburgh, J}
}
